Free Trial

VanEck Bionic Engineering UCITS ETF A Acc (CYBG) Competitors

GBX 13.48 +0.22 (+1.63%)
As of 06/5/2026 12:18 PM Eastern

CYBG vs. CCFS, CIHL, IL0A, SLS, and TRG

Should you buy VanEck Bionic Engineering UCITS ETF A Acc stock or one of its competitors? MarketBeat compares VanEck Bionic Engineering UCITS ETF A Acc with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with VanEck Bionic Engineering UCITS ETF A Acc include Charter Court Financial Services Grp (CCFS), Caribbean Investment (CIHL), Permanent TSB Group (IL0A), Standard Life UK Smaller Companies Trust (SLS), and The European Smaller Companies Trust (TRG).

How does VanEck Bionic Engineering UCITS ETF A Acc compare to Charter Court Financial Services Grp?

VanEck Bionic Engineering UCITS ETF A Acc (LON:CYBG) and Charter Court Financial Services Grp (LON:CCFS) are both small-cap finance companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, profitability, risk, valuation, institutional ownership, dividends, media sentiment and earnings.

Company Net Margins Return on Equity Return on Assets
VanEck Bionic Engineering UCITS ETF A AccN/A N/A N/A
Charter Court Financial Services Grp N/A N/A N/A

VanEck Bionic Engineering UCITS ETF A Acc pays an annual dividend of GBX 0.03 per share and has a dividend yield of 0.2%. Charter Court Financial Services Grp pays an annual dividend of GBX 0.09 per share. VanEck Bionic Engineering UCITS ETF A Acc pays out -0.4% of its earnings in the form of a dividend. Charter Court Financial Services Grp pays out 0.2% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. VanEck Bionic Engineering UCITS ETF A Acc is clearly the better dividend stock, given its higher yield and lower payout ratio.

VanEck Bionic Engineering UCITS ETF A Acc is trading at a lower price-to-earnings ratio than Charter Court Financial Services Grp, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
VanEck Bionic Engineering UCITS ETF A Acc£1.24B0.16N/A-£7.10N/A
Charter Court Financial Services Grp£221.10M0.00N/A£46.30N/A

In the previous week, VanEck Bionic Engineering UCITS ETF A Acc's average media sentiment score of 0.00 equaled Charter Court Financial Services Grp'saverage media sentiment score.

Summary

VanEck Bionic Engineering UCITS ETF A Acc beats Charter Court Financial Services Grp on 3 of the 5 factors compared between the two stocks.

How does VanEck Bionic Engineering UCITS ETF A Acc compare to Caribbean Investment?

Caribbean Investment (LON:CIHL) and VanEck Bionic Engineering UCITS ETF A Acc (LON:CYBG) are both small-cap banks - regional - europe industry companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, profitability, analyst recommendations, valuation, institutional ownership, media sentiment, dividends and risk.

Company Net Margins Return on Equity Return on Assets
Caribbean InvestmentN/A N/A N/A
VanEck Bionic Engineering UCITS ETF A Acc N/A N/A N/A

VanEck Bionic Engineering UCITS ETF A Acc is trading at a lower price-to-earnings ratio than Caribbean Investment, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Caribbean Investment£29.20M0.00N/A£8.60N/A
VanEck Bionic Engineering UCITS ETF A Acc£1.24B0.16N/A-£7.10N/A

In the previous week, Caribbean Investment's average media sentiment score of 0.00 equaled VanEck Bionic Engineering UCITS ETF A Acc'saverage media sentiment score.

Company Overall Sentiment
Caribbean Investment Neutral
VanEck Bionic Engineering UCITS ETF A Acc Neutral

Summary

Caribbean Investment beats VanEck Bionic Engineering UCITS ETF A Acc on 2 of the 3 factors compared between the two stocks.

How does VanEck Bionic Engineering UCITS ETF A Acc compare to Permanent TSB Group?

VanEck Bionic Engineering UCITS ETF A Acc (LON:CYBG) and Permanent TSB Group (LON:IL0A) are both small-cap finance companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, dividends, earnings, risk, valuation, profitability, media sentiment and analyst recommendations.

5.4% of Permanent TSB Group shares are owned by institutional investors. 79.1% of Permanent TSB Group shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Permanent TSB Group has a net margin of 54.93% compared to VanEck Bionic Engineering UCITS ETF A Acc's net margin of 0.00%. Permanent TSB Group's return on equity of 10.65% beat VanEck Bionic Engineering UCITS ETF A Acc's return on equity.

Company Net Margins Return on Equity Return on Assets
VanEck Bionic Engineering UCITS ETF A AccN/A N/A N/A
Permanent TSB Group 54.93%10.65%0.93%

In the previous week, VanEck Bionic Engineering UCITS ETF A Acc's average media sentiment score of 0.00 equaled Permanent TSB Group'saverage media sentiment score.

Company Overall Sentiment
VanEck Bionic Engineering UCITS ETF A Acc Neutral
Permanent TSB Group Neutral

Permanent TSB Group has lower revenue, but higher earnings than VanEck Bionic Engineering UCITS ETF A Acc. VanEck Bionic Engineering UCITS ETF A Acc is trading at a lower price-to-earnings ratio than Permanent TSB Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
VanEck Bionic Engineering UCITS ETF A Acc£1.24B0.16N/A-£7.10N/A
Permanent TSB Group£406M0.00£213M£0.43N/A

Summary

Permanent TSB Group beats VanEck Bionic Engineering UCITS ETF A Acc on 7 of the 8 factors compared between the two stocks.

How does VanEck Bionic Engineering UCITS ETF A Acc compare to Standard Life UK Smaller Companies Trust?

VanEck Bionic Engineering UCITS ETF A Acc (LON:CYBG) and Standard Life UK Smaller Companies Trust (LON:SLS) are both small-cap finance companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, institutional ownership, analyst recommendations, valuation, media sentiment, profitability, earnings and risk.

In the previous week, VanEck Bionic Engineering UCITS ETF A Acc's average media sentiment score of 0.00 equaled Standard Life UK Smaller Companies Trust'saverage media sentiment score.

VanEck Bionic Engineering UCITS ETF A Acc pays an annual dividend of GBX 0.03 per share and has a dividend yield of 0.2%. Standard Life UK Smaller Companies Trust pays an annual dividend of GBX 0.08 per share. VanEck Bionic Engineering UCITS ETF A Acc pays out -0.4% of its earnings in the form of a dividend. Standard Life UK Smaller Companies Trust pays out 0.0% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. VanEck Bionic Engineering UCITS ETF A Acc is clearly the better dividend stock, given its higher yield and lower payout ratio.

Company Net Margins Return on Equity Return on Assets
VanEck Bionic Engineering UCITS ETF A AccN/A N/A N/A
Standard Life UK Smaller Companies Trust N/A N/A N/A

VanEck Bionic Engineering UCITS ETF A Acc is trading at a lower price-to-earnings ratio than Standard Life UK Smaller Companies Trust, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
VanEck Bionic Engineering UCITS ETF A Acc£1.24B0.16N/A-£7.10N/A
Standard Life UK Smaller Companies Trust£222.48M0.00N/A£217.40N/A

Summary

VanEck Bionic Engineering UCITS ETF A Acc beats Standard Life UK Smaller Companies Trust on 3 of the 5 factors compared between the two stocks.

How does VanEck Bionic Engineering UCITS ETF A Acc compare to The European Smaller Companies Trust?

VanEck Bionic Engineering UCITS ETF A Acc (LON:CYBG) and The European Smaller Companies Trust (LON:TRG) are both small-cap finance companies, but which is the better business? We will contrast the two businesses based on the strength of their earnings, profitability, risk, valuation, media sentiment, analyst recommendations, institutional ownership and dividends.

Company Net Margins Return on Equity Return on Assets
VanEck Bionic Engineering UCITS ETF A AccN/A N/A N/A
The European Smaller Companies Trust N/A N/A N/A

VanEck Bionic Engineering UCITS ETF A Acc is trading at a lower price-to-earnings ratio than The European Smaller Companies Trust, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
VanEck Bionic Engineering UCITS ETF A Acc£1.24B0.16N/A-£7.10N/A
The European Smaller Companies Trust£340.08M0.00N/A£82.00N/A

VanEck Bionic Engineering UCITS ETF A Acc pays an annual dividend of GBX 0.03 per share and has a dividend yield of 0.2%. The European Smaller Companies Trust pays an annual dividend of GBX 0.03 per share. VanEck Bionic Engineering UCITS ETF A Acc pays out -0.4% of its earnings in the form of a dividend. The European Smaller Companies Trust pays out 0.0% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. VanEck Bionic Engineering UCITS ETF A Acc is clearly the better dividend stock, given its higher yield and lower payout ratio.

In the previous week, VanEck Bionic Engineering UCITS ETF A Acc's average media sentiment score of 0.00 equaled The European Smaller Companies Trust'saverage media sentiment score.

Summary

VanEck Bionic Engineering UCITS ETF A Acc beats The European Smaller Companies Trust on 3 of the 5 factors compared between the two stocks.

Get VanEck Bionic Engineering UCITS ETF A Acc News Delivered to You Automatically

Sign up to receive the latest news and ratings for CYBG and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CYBG vs. The Competition

MetricVanEck Bionic Engineering UCITS ETF A AccBanks IndustryFinance SectorLON Exchange
Market Cap£193.31M£193.31M£13.56B£2.75B
Dividend Yield2.25%2.25%5.80%6.16%
P/E Ratio-1.90N/A19.92366.37
Price / Sales0.1615.61137.0287,126.19
Price / Cash0.130.1319.1527.85
Price / Book0.040.042.187.68
Net IncomeN/AN/A£1.13B£5.89B
7 Day Performance2.35%0.47%-0.31%-0.50%
1 Month Performance2.78%0.56%-0.61%1.84%
1 Year PerformanceN/A-2.45%10.77%72.87%

VanEck Bionic Engineering UCITS ETF A Acc Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CYBG
VanEck Bionic Engineering UCITS ETF A Acc
N/AGBX 13.48
+1.6%
N/AN/A£193.31M£1.24BN/A5,762
CCFS
Charter Court Financial Services Grp
N/AN/AN/AN/A£713.62M£221.10M6.37676
CIHL
Caribbean Investment
N/AN/AN/AN/A£35.27M£29.20M3.08N/A
IL0A
Permanent TSB Group
N/AN/AN/AN/A£12.99M£406M5.532,236
SLS
Standard Life UK Smaller Companies Trust
N/AN/AN/AN/A£715.41M£222.48M3.3710

Related Companies and Tools


This page (LON:CYBG) was last updated on 6/7/2026 by MarketBeat.com Staff.
From Our Partners